GLENCET

This brand name is authorized in Ecuador, Hong Kong, Nigeria, South Africa

Active ingredients

The drug GLENCET contains one active pharmaceutical ingredient (API):

1 Levocetirizine UNII W69HSF2416 - LEVOCETIRIZINE HYDROCHLORIDE

Levocetirizine, the ® enantiomer of cetirizine, is a potent and selective antagonist of peripheral H1-receptors. Pharmacodynamic studies in healthy volunteers demonstrate that, at half the dose, levocetirizine has comparable activity to cetirizine, both in the skin and in the nose. Read about Levocetirizine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R06AE09	Levocetirizine	R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AE Piperazine derivatives
Discover more medicines within R06AE09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 5443-MEE-0820
Country: HK	Department of Health Drug Office	Identifier(s): 65056
Country: NG	Registered Drug Product Database	Identifier(s): B4-3090
Country: ZA	Health Products Regulatory Authority	Identifier(s): 44/5.7.1/0843